Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & Administrative
Others
Ratios

Bone Biologics (BBLG) EPS (Basic) (2016 - 2017)

Bone Biologics (BBLG) has disclosed EPS (Basic) for 2 consecutive years, with -$0.71 as the latest value for Q4 2017.

  • On a quarterly basis, EPS (Basic) fell 610.0% to -$0.71 in Q4 2017 year-over-year; TTM through Dec 2017 was -$0.82, a 18.84% decrease, with the full-year FY2025 number at -$2.65, up 90.85% from a year prior.
  • EPS (Basic) was -$0.71 for Q4 2017 at Bone Biologics, down from -$0.06 in the prior quarter.
  • In the past five years, EPS (Basic) ranged from a high of $0.03 in Q2 2017 to a low of -$0.71 in Q4 2017.